Related references
Note: Only part of the references are listed.Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?
Fernanda R. C. Giachini et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Mechanisms of ET-1-induced endothelial dysfunction
Marc Iglarz et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Effect of dehydroepiandrosterone on insulin sensitivity in Otsuka Long-Evans Tokushima-fatty rats
Tatsuo Ishizuka et al.
ACTA DIABETOLOGICA (2007)
In vitro effect of dehydroepiandrosterone sulfate on steroid receptors, aromatase, cyclooxygenase-2 expression, and steroid hormone production in preovulatory human granulosa cells
Khalid ELBeltagy et al.
FERTILITY AND STERILITY (2007)
Cardiovascular actions of insulin
Ranganath Muniyappa et al.
ENDOCRINE REVIEWS (2007)
Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Gαi protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression
Dongmin Liu et al.
ENDOCRINOLOGY (2007)
Dietary supplements and nutraceuticals in the management of andrologic disorders
Ronald Tamler et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2007)
EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR
Maria A. Potenza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Fluid shear stress and NO decrease the activity of the hydroxy-methylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxO1
Beate Fisslthaler et al.
CIRCULATION RESEARCH (2007)
Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance
Maria A. Potenza et al.
DIABETES (2006)
DHEA in elderly women and DHEA or testosterone in elderly men
K. Sreekumaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
Christopher Daly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
FOXO1 represses peroxisome proliferator-activated receptor-γ1 and -γ2 gene promoters in primary adipocytes -: A novel paradigm to increase insulin sensitivity
Michal Armoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium
G Formoso et al.
MOLECULAR ENDOCRINOLOGY (2006)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
The effect of dehydroepiandrosterone sulfate (DHEAS) on myotonia: Intracellular studies
H Nakazora et al.
INTERNAL MEDICINE (2005)
Dehydroepiandrosterone restoration of growth hormone gene expression in aging female rats, in vivo and in vitro:: Evidence for actions via estrogen receptors
M Iruthayanathan et al.
ENDOCRINOLOGY (2005)
FOXO transcription factors at the interface between longevity and tumor suppression
EL Greer et al.
ONCOGENE (2005)
Direct agonist/antagonist functions of dehydroepiandrosterone
F Chen et al.
ENDOCRINOLOGY (2005)
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
JH Chen et al.
NATURE MEDICINE (2005)
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization
M Potente et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production
MA Potenza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Skp2 inhibits FOX01 in tumor suppression through ubiquitin-mediated degradation
H Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor
DM Liu et al.
STEROIDS (2004)
Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification
T Hosaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors
MRI Williams et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice
T Furuyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies
A Tchernof et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation
LP van der Heide et al.
BIOCHEMICAL JOURNAL (2004)
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane
S Perrini et al.
DIABETES (2004)
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation
D Accili et al.
CELL (2004)
Adiponectin stimulates production of nitric oxide in vascular endothelial cells
H Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
H Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
11,12-epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1
M Potente et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms
T Simoncini et al.
ENDOCRINOLOGY (2003)
Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men
H Kawano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Effect of 1-year oral administration of dehydroepiandrosterone to 60-to 80-year-old individuals on muscle function and cross-sectional area - A double-blind placebo-controlled trial
G Percheron et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1
J Nakai et al.
NATURE GENETICS (2002)
The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity
BL Lasley et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Gαi2,3
DM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Vezf1/DB1 is an endothelial cell-specific transcription factor that regulates expression of the endothelia-1 promoter
J Aitsebaomo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality
L Mazat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effects of DHEA replacement on bone mineral density and body composition in elderly women and men
DT Villareal et al.
CLINICAL ENDOCRINOLOGY (2000)
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause
M Stomati et al.
GYNECOLOGICAL ENDOCRINOLOGY (2000)
Interaction of endothelin-1 and nitric oxide in endothelial barrier failure in the cat hindlimb
LP Porter et al.
MICROCIRCULATION (2000)
Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle
K Cusi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
The effects of dehydroepiandrosterone on carcinogenesis, obesity, the immune system, and aging
JR Williams
LIPIDS (2000)
Share Paper
